Meeder Asset Management Inc Amphastar Pharmaceuticals, Inc. Transaction History

Meeder Asset Management Inc

$1.48 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$27.56 - $37.75 $137 - $188	5 Added 2.94%	175 $5,000
Q2 2022 Aug 08, 2022	BUY	$29.79 - $42.29 $1,012 - $1,437	34 Added 25.0%	170 $6,000
Q1 2022 May 10, 2022	BUY	$22.96 - $36.45 $3,122 - $4,957	136 New	136 $5,000
Q4 2021 Feb 11, 2022	SELL	$18.14 - $23.29 $3,210 - $4,122	-177 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$17.83 - $21.49 $624 - $752	35 Added 24.65%	177 $3,000
Q2 2021 Aug 09, 2021	BUY	$17.11 - $20.92 $136 - $167	8 Added 5.97%	142 $3,000
Q1 2021 Apr 28, 2021	BUY	$17.21 - $20.65 $447 - $536	26 Added 24.07%	134 $2,000
Q4 2020 Feb 09, 2021	SELL	$17.76 - $21.24 $568 - $679	-32 Reduced 22.86%	108 $2,000
Q3 2020 Nov 02, 2020	BUY	$17.99 - $22.22 $1,061 - $1,310	59 Added 72.84%	140 $3,000
Q2 2020 Aug 11, 2020	SELL	$14.25 - $22.46 $2,679 - $4,222	-188 Reduced 69.89%	81 $2,000
Q1 2020 May 15, 2020	SELL	$12.66 - $20.08 $6,912 - $10,963	-546 Reduced 66.99%	269 $4,000
Q4 2019 Feb 13, 2020	BUY	$17.07 - $20.64 $1,399 - $1,692	82 Added 11.19%	815 $16,000
Q3 2019 Oct 17, 2019	SELL	$19.12 - $22.62 $210,472 - $249,000	-11,008 Reduced 93.76%	733 $15,000
Q2 2019 Aug 05, 2019	SELL	$18.92 - $22.96 $69,152 - $83,918	-3,655 Reduced 23.74%	11,741 $249,000
Q1 2019 Apr 16, 2019	BUY	$19.46 - $25.28 $209,486 - $272,139	10,765 Added 232.46%	15,396 $315,000
Q4 2018 Jan 17, 2019	BUY	$17.72 - $22.51 $82,061 - $104,243	4,631 New	4,631 $92,000
Q3 2018 Nov 02, 2018	SELL	$15.39 - $19.38 $161,379 - $203,218	-10,486 Closed	0 $0
Q2 2018 Jul 24, 2018	BUY	$14.63 - $19.6 $110,778 - $148,411	7,572 Added 259.85%	10,486 $0
Q1 2018 May 03, 2018	BUY	$17.23 - $20.35 $5,065 - $5,982	294 Added 11.22%	2,914 $55,000
Q4 2017 Feb 02, 2018	BUY	$17.76 - $19.75 $41,949 - $46,649	2,362 Added 915.5%	2,620 $50,000
Q3 2017 Oct 20, 2017	BUY	$14.73 - $17.99 $3,800 - $4,641	258	258 $5,000

Others Institutions Holding AMPH

# of Institutions

286

Shares Held

34.9M

Call Options Held

74.3K

Put Options Held

22.3K

View Full List

About Amphastar Pharmaceuticals, Inc.

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.92B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

More about AMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.

Account